Amanote Research
Register
Sign In
278. Challenges in the Manufacturing of Retroviral Gene Therapy Vectors
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)37719-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2010
Authors
Unknown
Publisher
Elsevier BV
Related search
Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Q Vectors, Bicistronic Retroviral Vectors for Gene Transfer
BioTechniques
Biochemistry
Biotechnology
Genetics
Molecular Biology
Lentiviral Gene Therapy Vectors: Challenges and Future Directions
E- Vectors: Development of Novel Self-Inactivating and Self-Activating Retroviral Vectors for Safer Gene Therapy.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Provision of Positive and Negative Selections in Retroviral Vectors Containing the Cytosine Deaminase Gene
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Regulated Gene Expression in the Chicken Embryo by Using Replication-Competent Retroviral Vectors
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Gene Delivery Into the Chicken Embryo by Using Replication-Competent Retroviral Vectors
Fukushima Journal of Medical Sciences
Medicine
Adenovirus Vectors for Gene Therapy
Uirusu. Journal of virology
Medicine